ENTITY
SMARTSCORE: 3.4/5
Astellas Pharma

Astellas Pharma (4503 JP)

164
Analysis
Health CareJapan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
more
12 Mar 2017 07:15

The Week That Was in NorthAsia@Smartkarma

This is the second report of "The Week That Was in North Asia@Smartkarma". This is a collaborative report among Travis Lundy, Mio Kato, CFA,...

Logo
374 Views
Share
04 Mar 2017 03:12

The Week That Was in NorthAsia@Smartkarma - Jelly Drinks, Dental Implants, & Tires

This is the inaugural report of "The Week That Was in North Asia@Smartkarma. This is a collaborative report among Travis Lundy, Mio Kato, CFA,...

Logo
384 Views
Share
27 Feb 2017 06:28

AI & Machine Learning Disrupting The Healthcare Industry

In the omnipresence of machine learning, one of the most impacted segments is healthcare. Not only is AI in healthcare at the forefront of a...

Logo
659 Views
Share
30 Jan 2017 05:50

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

AML represents one of the largest hematologic cancer populations with one of the worst survival rates. Global prevalence is expected to increase at...

bullishAstellas Pharma
23 Dec 2016 07:01

Xtandi (Enzalutamide) – Second Generation Androgen Receptor (AR) Signalling Inhibitor

While most of its peers struggle getting traction with new launches, Astellas is in a fortunate situation with its recently launched prostate...

x